We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
-5.08%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.82B
AUM Growth
-$690M
Cap. Flow
-$124M
Cap. Flow %
-2.58%
Top 10 Hldgs %
17.51%
Holding
1,588
New
254
Increased
693
Reduced
409
Closed
141

Top Buys

Rank Stock Value
1
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
+$50.6M
2
CAT icon
Caterpillar
CAT
+$27M
3
ADI icon
Analog Devices
ADI
+$22.8M
4
CSX icon
CSX Corp
CSX
+$20.1M
5
PTY icon
PIMCO Corporate & Income Opportunity Fund
PTY
+$15M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$24.6M
2
BCX icon
BlackRock Resources & Commodities Strategy Trust
BCX
+$22.3M
3
MXIM
Maxim Integrated Products
MXIM
+$21.2M
4
NFJ
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
+$21.1M
5
VVR icon
Invesco Senior Income Trust
VVR
+$19.6M

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Consumer Discretionary 25.32%
3 Communication Services 11.6%
4 Industrials 6.01%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1176
Bristol-Myers Squibb
BMY
$132B
$30K ﹤0.01%
522
+117
+29% +$7.71K
EL icon
1177
Estee Lauder
EL
$32B
$30K ﹤0.01%
102
-18
-15% -$5.88K
FOA icon
1178
Finance of America Companies
FOA
$198M
$30K ﹤0.01%
617
-483
-44% -$28.7K
LDEM icon
1179
iShares ESG MSCI EM Leaders ETF
LDEM
$33.5M
$30K ﹤0.01%
+504
New +$31.6K
MDGL icon
1180
Madrigal Pharmaceuticals
MDGL
$11.8B
$30K ﹤0.01%
380
– –
NAUT icon
1181
Nautilus Biotechnolgy
NAUT
$115M
$30K ﹤0.01%
4,964
+210
+4% +$1.67K
NRIX icon
1182
Nurix Therapeutics
NRIX
$2.65B
$30K ﹤0.01%
1,015
+5
+0.5% +$154
OPFI icon
1183
OppFi
OPFI
$803M
$30K ﹤0.01%
3,861
-4,145
-52% -$36.5K
PCVX icon
1184
Vaxcyte
PCVX
$8.64B
$30K ﹤0.01%
1,195
+25
+2% +$606
SRE icon
1185
Sempra
SRE
$54.8B
$30K ﹤0.01%
480
+170
+55% +$11.2K
BLUE
1186
DELISTED
bluebird bio
BLUE
$29K ﹤0.01%
119
– –
IBKR icon
1187
Interactive Brokers
IBKR
$39.8B
$29K ﹤0.01%
+1,920
New +$30.2K
LAD icon
1188
Lithia Motors
LAD
$8.26B
$29K ﹤0.01%
92
+8
+10% +$2.79K
MGNX icon
1189
MacroGenics
MGNX
$257M
$29K ﹤0.01%
1,400
+35
+3% +$843
MS icon
1190
Morgan Stanley
MS
$340B
$29K ﹤0.01%
300
+50
+20% +$4.95K
SGMO
1191
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$29K ﹤0.01%
3,325
+50
+2% +$494
BGRY
1192
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$29K ﹤0.01%
4,231
-2,577
-38% -$22K
ARCT icon
1193
Arcturus Therapeutics
ARCT
$211M
$28K ﹤0.01%
605
+5
+0.8% +$224
AXSM icon
1194
Axsome Therapeutics
AXSM
$10.9B
$28K ﹤0.01%
865
+10
+1% +$390
CHRS icon
1195
Coherus Oncology
CHRS
$196M
$28K ﹤0.01%
1,750
+25
+1% +$366
KURA icon
1196
Kura Oncology
KURA
$850M
$28K ﹤0.01%
1,515
+5
+0.3% +$94
TJX icon
1197
TJX Companies
TJX
$178B
$28K ﹤0.01%
438
-2
-0.5% -$140
TW icon
1198
Tradeweb Markets
TW
$21.6B
$28K ﹤0.01%
+347
New +$29.9K
YMAB
1199
DELISTED
Y-mAbs Therapeutics
YMAB
$28K ﹤0.01%
995
+5
+0.5% +$158
APD icon
1200
Air Products & Chemicals
APD
$67.6B
$27K ﹤0.01%
108
+23
+27% +$6.36K
46 47
48
49 50

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Penserra Capital Management held 1,588 positions worth $4.82B, down 13% from $5.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Penserra Capital Management's Q3 2021 filing shows 254 new, 693 increased, 409 reduced and 141 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M. The largest sale was Baidu, an estimated $24.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M.
  • Penserra Capital Management added most to Analog Devices in Q3 2021, an estimated $22.8M increase.
  • Penserra Capital Management's biggest Q3 2021 reduction was Baidu, cutting an estimated $24.6M.
  • Penserra Capital Management fully exited BlackRock Resources & Commodities Strategy Trust in Q3 2021, selling an estimated $22.3M.
  • Penserra Capital Management's ten largest holdings make up 18% of its $4.82B portfolio in Q3 2021.
  • Penserra Capital Management opened 254 new positions and closed 141 in Q3 2021.
  • Penserra Capital Management's portfolio value fell 13% quarter-over-quarter to $4.82B.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.